American Society of Clinical Oncology 2021 Annual Meeting updates on primary brain tumors and CNS metastatic tumors.

Baskaran, Archit B; Kumthekar, Priya; Heimberger, Amy B; Lukas, Rimas V

Baskaran, Archit B; Kumthekar, Priya; Heimberger, Amy B; Lukas, Rimas V.

Afiliación

Baskaran AB; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Kumthekar P; Department of Neurology, Northwestern University, Chicago, IL, USA.
Heimberger AB; Lou & Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL, USA.
Lukas RV; Lou & Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL, USA.

Future Oncol ; 17(33): 4425-4429, 2021 Nov.

Article en En | MEDLINE | ID: mdl-34672682

RESUMEN

In this report, select key studies presented at the American Society of Clinical Oncology (ASCO) 2021 annual meeting are reviewed. Two major phase III randomized controlled trials were presented at the meeting: GEINO 1401 and EORTC 1709/CCTG CE.8. Both are reviewed in this report. Moreover, important phase II trials, including Alliance A0716701, and key phase I trials are included. All trials presented cover important advances in the understanding of primary brain tumor management. In addition, case series papers, trials in progress and select work on exploratory CSF biomarkers are reviewed. Altogether, research presented at ASCO 2021 highlights important advances in neuro-oncologic topics that may inform future research and practice.

Palabras clave

brain metastases; craniopharyngioma; glioblastoma; leptomeningeal metastases; meeting report; neuro-oncology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Future Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google